Position in STTK
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$158,730
-$42,762 QoQ
Shares Held
24,686
-52.7% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in STTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Jump Financial, LLC holds $229,872,118 across 133 Biotechnology names. STTK ranks #105 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
206,675 | $15,519,225 | |
| 2 | SRPT |
Sarepta Therapeutics, Inc.
|
507,828 | $11,050,335 | |
| 3 | RARE |
Ultragenyx Pharmaceutical Inc.
|
504,143 | $10,561,795 | |
| 4 | LEGN |
Legend Biotech Corp
|
516,633 | $9,345,890 | |
| 5 | XENE |
Xenon Pharmaceuticals Inc.
|
155,776 | $9,058,374 | |
| 6 | BNTX |
BioNTech SE
|
79,189 | $7,038,317 | |
| 7 | OLMA |
Olema Pharmaceuticals, Inc.
|
452,966 | $6,753,723 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
19,152 | $6,336,822 |
All Filings in STTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $158,730 | 24,686 | Shares | Defined | 2026-05-14 | |
| 2024-06-30 | $201,492 | 52,200 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $286,955 | 32,098 | Shares | Sole | 2024-05-13 | |
| 2022-06-30 | $67,396 | 16,600 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $100,962 | 23,700 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $279,979 | 32,900 | Shares | Sole | 2022-02-10 | |
| No filing history on record for this holder in this stock. | ||||||